nitroaspirin has been researched along with Hypercholesterolemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackah, E; Condorelli, M; Crimi, E; D'Armiento, FP; De Nigris, F; Del Soldato, P; Napoli, C; Sessa, WC | 1 |
Granger, DN; Specian, RD; Tailor, A; Wallace, JL; Wood, KC | 1 |
Cirino, G; Condorelli, M; Del Soldato, P; Ignarro, LJ; Napoli, C; Pinto, A; Sica, V; Sorrentino, R | 1 |
3 other study(ies) available for nitroaspirin and Hypercholesterolemia
Article | Year |
---|---|
Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Aspirin; Foam Cells; Hypercholesterolemia; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Donors; Oxidation-Reduction; Oxidative Stress; Receptors, LDL | 2002 |
Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction.
Topics: Animals; Aspirin; Blood Platelets; Bone Marrow Transplantation; Cardiovascular Diseases; Cell Adhesion; Chimera; Cholesterol, Dietary; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Hypercholesterolemia; Leukocytes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Microscopy, Video; Nitric Oxide Donors; Platelet Adhesiveness; Pyrazoles; Venules | 2007 |
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.
Topics: Animals; Aspirin; Constriction, Pathologic; Hypercholesterolemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Receptors, LDL; Recurrence | 2001 |